Literature DB >> 9444957

Ets transcription factors bind and transactivate the core promoter of the von Willebrand factor gene.

J L Schwachtgen1, N Janel, L Barek, M Duterque-Coquillaud, J Ghysdael, D Meyer, D Kerbiriou-Nabias.   

Abstract

von Willebrand factor (vWF) gene expression is restricted to endothelial cells and megakaryocytes. Previous results demonstrated that basal transcription of the human vWF gene is mediated through a promoter located between base pairs -89 and +19 (cap site: +1) which is functional in endothelial and non endothelial cells. Two DNA repeats TTTCCTTT correlating with inverted consensus binding sites for the Ets family of transcription factors are present in the -56/-36 sequence. In order to analyse whether these DNA elements are involved in transcription, human umbilical vein endothelial cells (HUVEC), bovine calf pulmonary endothelial cell line (CPAE), HeLa and COS cells were transfected with constructs containing deletions of the -89/+19 fragment, linked to the chloramphenicol acetyl transferase (CAT) reporter gene. The -60/+19 region exhibits significant promoter activity in HUVEC and CPAE cells only. The -42/+19 fragment is not active. Mutations of the -60/+19 promoter fragment in the 5' (-56/-49) Ets binding site abolish transcription in endothelial cells whereas mutations in the 3' (-43/-36) site does not. The -60/-33 fragment forms three complexes with proteins from HUVEC nuclear extracts in electrophoretic mobility shift assay which are dependent on the presence of the 5' Ets binding site. Binding of recombinant Ets-1 protein to the -60/-33 fragment gives a complex which also depends on the 5' site. The -60/+19 vWF gene core promoter is transactivated in HeLa cells by cotransfecting with Ets-1 or Erg (Ets-related gene) expression plasmids. In contrast to the wild type construct, transcription of the 5' site mutants is not increased by these expressed proteins. The results indicate that the promoter activity of the -60/+19 region of the vWF gene depends on transcription factors of the Ets family of which several members like Ets-1, Ets-2 and Erg are expressed in endothelium. Cotransfection of Ets-1 and Erg expression plasmids is sufficient to induce the -60/+19 vWF promoter activity in HeLa cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9444957     DOI: 10.1038/sj.onc.1201502

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  24 in total

1.  RhoJ is an endothelial cell-restricted Rho GTPase that mediates vascular morphogenesis and is regulated by the transcription factor ERG.

Authors:  Lei Yuan; Anastasia Sacharidou; Amber N Stratman; Alexandra Le Bras; Peter J Zwiers; Katherine Spokes; Manoj Bhasin; Shou-Ching Shih; Janice A Nagy; Grietje Molema; William C Aird; George E Davis; Peter Oettgen
Journal:  Blood       Date:  2011-05-31       Impact factor: 22.113

Review 2.  Regulation of endothelial cell development by ETS transcription factors.

Authors:  Stryder M Meadows; Candace T Myers; Paul A Krieg
Journal:  Semin Cell Dev Biol       Date:  2011-09-18       Impact factor: 7.727

3.  Repressors NFI and NFY participate in organ-specific regulation of von Willebrand factor promoter activity in transgenic mice.

Authors:  Marjan Nassiri; Ju Liu; Stephen Kulak; Richard R E Uwiera; William C Aird; Barbara J Ballermann; Nadia Jahroudi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-04-29       Impact factor: 8.311

4.  Tescalcin is an essential factor in megakaryocytic differentiation associated with Ets family gene expression.

Authors:  Konstantin Levay; Vladlen Z Slepak
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

5.  Ets family protein, erg expression in developing and adult mouse tissues by a highly specific monoclonal antibody.

Authors:  Ahmed A Mohamed; Shyh-Han Tan; Natallia Mikhalkevich; Sathibalan Ponniah; Valeri Vasioukhin; Charles J Bieberich; Isabell A Sesterhenn; Albert Dobi; Shiv Srivastava; Taduru L Sreenath
Journal:  J Cancer       Date:  2010-10-25       Impact factor: 4.207

6.  A +220 GATA motif mediates basal but not endotoxin-repressible expression of the von Willebrand factor promoter in Hprt-targeted transgenic mice.

Authors:  J Liu; Y Kanki; Y Okada; E Jin; K Yano; S-C Shih; T Minami; W C Aird
Journal:  J Thromb Haemost       Date:  2009-05-30       Impact factor: 5.824

7.  Antiinflammatory effects of the ETS factor ERG in endothelial cells are mediated through transcriptional repression of the interleukin-8 gene.

Authors:  Lei Yuan; Vesna Nikolova-Krstevski; Yumei Zhan; Maiko Kondo; Manoj Bhasin; Laya Varghese; Kiichiro Yano; Chris V Carman; William C Aird; Peter Oettgen
Journal:  Circ Res       Date:  2009-04-09       Impact factor: 17.367

Review 8.  Regulation of VWF expression, and secretion in health and disease.

Authors:  Yaozu Xiang; John Hwa
Journal:  Curr Opin Hematol       Date:  2016-05       Impact factor: 3.284

9.  Alterations in transcriptional responses associated with vascular aging.

Authors:  Yumei Zhan; Lei Yuan; Peter Oettgen
Journal:  J Inflamm (Lond)       Date:  2009-05-21       Impact factor: 4.981

10.  ERG is required for the differentiation of embryonic stem cells along the endothelial lineage.

Authors:  Vesna Nikolova-Krstevski; Lei Yuan; Alexandra Le Bras; Preethi Vijayaraj; Maiko Kondo; Isabel Gebauer; Manoj Bhasin; Chris V Carman; Peter Oettgen
Journal:  BMC Dev Biol       Date:  2009-12-23       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.